Nutex Health (NUTX) Depreciation & Amortization (CF) (2010 - 2026)

Nutex Health (NUTX) has 17 years of Depreciation & Amortization (CF) data on file, last reported at $5.5 million in Q1 2026.

• Quarterly Depreciation & Amortization (CF) rose 7.86% year-over-year to $5.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $20.9 million (up 5.29% YoY) and the FY2025 annual result came in at $20.5 million, up 8.21% from the prior year.
• Depreciation & Amortization (CF) climbed to $5.5 million in Q1 2026 per NUTX's latest filing, from $5.2 million in the prior quarter.
• The five-year high for Depreciation & Amortization (CF) was $5.5 million in Q1 2026, with the low at $2.4 million in Q1 2022.
• Average Depreciation & Amortization (CF) over 5 years is $4.5 million, with a median of $4.7 million recorded in 2023.
• The widest YoY moves for Depreciation & Amortization (CF): up 3642.52% in 2022, down 20.45% in 2022.
• Nutex Health's Depreciation & Amortization (CF) stood at $3.3 million in 2022, then soared by 43.13% to $4.7 million in 2023, then rose by 12.77% to $5.3 million in 2024, then slipped by 1.78% to $5.2 million in 2025, then rose by 5.88% to $5.5 million in 2026.
• Business Quant data shows NUTX's Depreciation & Amortization (CF) at $5.5 million in Q1 2026, $5.2 million in Q4 2025, and $5.0 million in Q3 2025.